Abbott Laboratories reported impressive Q3 sales of $10.1B, driven by organic sales growth of 13.8%. The company's diversified portfolio showed growth across all major business segments, including ...
The CEO of Abbott Laboratories defended the company’s infant formula products Thursday, remarks that came as a trial continues this week in Missouri over allegations that Abbott’s formula led a ...
The healthcare conglomerate Abbott Laboratories said on Thursday it would buy Exact Sciences, makers of the at-home colon cancer test Cologuard, for roughly $21 billion. The deal appears to be the ...
Abbott Laboratories offers a compelling investment opportunity due to its resilience, consistent growth, and strong dividend record despite challenges in its COVID-19 diagnostic products and nutrition ...
A powerful storm that slammed Michigan and other states earlier this week forced parts of a key baby formula manufacturing plant in Michigan to halt production, the plant’s owner said. The ...
Chicago, IL – December 8, 2021 – Today, Zacks Equity Research discusses Medical Products, including Abbott Laboratories ABT, Bio-Rad Laboratories, Inc. BIO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback